Industry Roundup: Nexium 24HR Tablet, Glanbia Deal, FDA Warnings
This article was originally published in The Tan Sheet
Executive Summary
FDA approves Nexium 24HR tablet; Glanbia grabs thinkThin; Nature’s Mojo spooks FDA; warning shadow on Seeds Of Light; Mobius crowd-funds for launch; doctors mum on probiotics for IBS; and more news in brief.
You may also be interested in...
Health, Beauty And Wellness Launches: BSN, Som Sleep, Monat, Nutrisystem, Celsius, thinkThin
Monat enhances Rejuveniqe; Probiotics, protein in thinkThin oatmeal; Nutrisystem offers Blueprint for genetic action; Celsius powdered sticks in coconut, cranberry-lemon flavors; Som Sleep beverage available; and Cold Stone flavors BSN Syntha-6.
Industry News: Twinlab Into Resveratrol, Hi-Tech Buys LG Brands
Consent decree for Iowa Select; Hi-Tech extends into sports nutrition with LG brands; NBTY adds another Coca-Cola exec to its top management; and more news in brief.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.